UPLC-Q/TOF MS standardized Chinese formula Xin-Ke-Shu for the treatment of atherosclerosis in a rabbit model - PubMed (original) (raw)
. 2014 Sep 25;21(11):1364-72.
doi: 10.1016/j.phymed.2014.05.009. Epub 2014 Jun 7.
Affiliations
- PMID: 24916703
- DOI: 10.1016/j.phymed.2014.05.009
UPLC-Q/TOF MS standardized Chinese formula Xin-Ke-Shu for the treatment of atherosclerosis in a rabbit model
Yue-Tao Liu et al. Phytomedicine. 2014.
Abstract
Xin-Ke-Shu (XKS), a patent traditional Chinese medicine (TCM) preparation, has been commonly used for the treatment of coronary heart disease in China. In order to understand its mechanism of action, a metabonomic approach based on ultra performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (UPLC-Q/TOF MS) was utilized to profile the plasma metabolic fingerprints of atherosclerosis (AS) rabbits with and without XKS treatment. The metabolic profile of model group clearly separated from normal, and that of XKS group was closer to the control group. Metabolites with significant changes during atherosclerosis were characterized as potential biomarkers related to the development of atherosclerosis by using orthogonal partial least-squares-discriminate analysis (OPLS-DA). Twenty potential biomarkers, including l-acetylcarnitine (1), propionylcarnitine (2), unknown (3), phytosphingosine (4), glycoursodeoxycholic acid (5), LPC(14:0) (6), sphinganine (7), LPC(20:5) (8), LPC(16:1) (9), LPC(18:2) (10), LPC(18:3) (11), LPC(22:5) (12), LPC(16:0) (13), LPC(18:1) (14), LPC(22:4) (15), LPC(17:0) (16), LPC(20:2) (17), elaidic carnitine (18), LPC(18:0) (19) and LPC(20:1) (20), were identified by their accurate mass and MS(E) spectra. The derivations of those biomarkers can be regulated by administration of XKS, which suggested that the intervention effect of XKS against AS may involve in regulating the lipid perturbation including fatty acid β-oxidation pathway, sphingolipid metabolism, glycerophospholipid metabolism and bile acid biosynthesis. This study indicated that the UPLC-Q/TOF MS-based metabonomics not only gave a systematic view of the pathomechanism of AS, but also provided a powerful tool to study the efficacy and mechanism of complex TCM prescriptions.
Keywords: Atherosclerosis; Lipid pathways; Pharmacological action; Plasma metabonomics; Xin-Ke-Shu.
Copyright © 2014 Elsevier GmbH. All rights reserved.
Similar articles
- Metabolic pathways involved in Xin-Ke-Shu protecting against myocardial infarction in rats using ultra high-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry.
Liu YT, Jia HM, Chang X, Cheng WH, Zhao X, Ding G, Zhang HW, Cai DY, Zou ZM. Liu YT, et al. J Pharm Biomed Anal. 2014 Mar;90:35-44. doi: 10.1016/j.jpba.2013.11.008. Epub 2013 Nov 15. J Pharm Biomed Anal. 2014. PMID: 24321516 - Chinese patent medicine Xin-Ke-Shu inhibits Ca2+ overload and dysfunction of fatty acid β-oxidation in rats with myocardial infarction induced by LAD ligation.
Yang Y, Jia H, Yu M, Zhou C, Sun L, Zhao Y, Zhang H, Zou Z. Yang Y, et al. J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Mar 15;1079:85-94. doi: 10.1016/j.jchromb.2018.01.038. Epub 2018 Feb 3. J Chromatogr B Analyt Technol Biomed Life Sci. 2018. PMID: 29454926 - From quality markers to data mining and intelligence assessment: A smart quality-evaluation strategy for traditional Chinese medicine based on quality markers.
Bai G, Zhang T, Hou Y, Ding G, Jiang M, Luo G. Bai G, et al. Phytomedicine. 2018 May 15;44:109-116. doi: 10.1016/j.phymed.2018.01.017. Epub 2018 Jan 31. Phytomedicine. 2018. PMID: 29426601 Review. - Metabolism and atherogenic disease association of lysophosphatidylcholine.
Schmitz G, Ruebsaamen K. Schmitz G, et al. Atherosclerosis. 2010 Jan;208(1):10-8. doi: 10.1016/j.atherosclerosis.2009.05.029. Epub 2009 Jun 6. Atherosclerosis. 2010. PMID: 19570538 Review.
Cited by
- Large-scale Metabolomic Analysis Reveals Potential Biomarkers for Early Stage Coronary Atherosclerosis.
Gao X, Ke C, Liu H, Liu W, Li K, Yu B, Sun M. Gao X, et al. Sci Rep. 2017 Sep 18;7(1):11817. doi: 10.1038/s41598-017-12254-1. Sci Rep. 2017. PMID: 28924163 Free PMC article. Clinical Trial. - Sanhuang Xiexin Tang Ameliorates Type 2 Diabetic Rats via Modulation of the Metabolic Profiles and NF-κB/PI-3K/Akt Signaling Pathways.
Wei X, Tao J, Shen Y, Xiao S, Jiang S, Shang E, Zhu Z, Qian D, Duan J. Wei X, et al. Front Pharmacol. 2018 Aug 28;9:955. doi: 10.3389/fphar.2018.00955. eCollection 2018. Front Pharmacol. 2018. PMID: 30210342 Free PMC article. - Promoting Human Nutrition and Health through Plant Metabolomics: Current Status and Challenges.
Sun W, Chen Z, Hong J, Shi J. Sun W, et al. Biology (Basel). 2020 Dec 31;10(1):20. doi: 10.3390/biology10010020. Biology (Basel). 2020. PMID: 33396370 Free PMC article. Review. - Feces and liver tissue metabonomics studies on the regulatory effect of aspirin eugenol eater in hyperlipidemic rats.
Ma N, Liu X, Kong X, Li S, Jiao Z, Qin Z, Dong P, Yang Y, Li J. Ma N, et al. Lipids Health Dis. 2017 Dec 11;16(1):240. doi: 10.1186/s12944-017-0633-0. Lipids Health Dis. 2017. PMID: 29228968 Free PMC article. - Serum metabolic signatures of subclinical atherosclerosis in patients with type 2 diabetes mellitus: a preliminary study.
Su J, Zhao Q, Zhao A, Jia W, Zhu W, Lu J, Ma X. Su J, et al. Acta Diabetol. 2021 Sep;58(9):1217-1224. doi: 10.1007/s00592-021-01717-7. Epub 2021 Apr 19. Acta Diabetol. 2021. PMID: 33871690
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials